Public Act No. 23-92 Summary

• Requires JUUL Labs settlement moneys to be disbursed to the Commissioner of Mental Health and Addiction Services for distribution to regional behavioral health action organizations for programs supporting cessation and prevention of nicotine use by residents under 21 years of age, with annual reporting required by September 1.

• Establishes an Opioid Settlement Fund as a separate nonlapsing fund to receive all moneys from opioid-related judgments, consent decrees, or settlements finalized on or after July 1, 2021, with funds restricted to evidence-based substance use disorder prevention, treatment, recovery, and harm reduction purposes.

• Authorizes tobacco manufacturers to permanently assign their escrow fund interests to the state, with assigned funds deposited into the Tobacco and Health Trust Fund and credited dollar-for-dollar against judgment or settlement obligations.

• Revises the Tobacco and Health Trust Fund to prioritize comprehensive tobacco and nicotine control programs including youth prevention, adult smoking cessation, elimination of secondhand smoke exposure, and elimination of tobacco-related health disparities.

• Requires nonparticipating tobacco manufacturers to appoint agents for service of process in Connecticut and post annual bonds equal to the greater of $25,000 or their highest annual escrow obligation from the preceding five years.